This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ben-Shushan, E.
Right arrow Articles by Bergman, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ben-Shushan, E.
Right arrow Articles by Bergman, Y.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 02 1995, 1034-1048, Vol 15, No. 2
Copyright © 1995, American Society for Microbiology

A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells

E Ben-Shushan, H Sharir, E Pikarsky and Y Bergman
Hubert H. Humphrey Center for Experimental Medicine and Cancer Research, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

The Oct-3/4 transcription factor is a member of the POU family of transcription factors and, as such, probably plays a crucial role in mammalian embryogenesis and differentiation. It is expressed in the earliest stages of embryogenesis and repressed in subsequent stages. Similarly, Oct-3/4 is expressed in embryonal carcinoma (EC) cells and is repressed in retinoic acid (RA)-differentiated EC cells. Previously we have shown that the Oct-3/4 promoter harbors an RA-responsive element, RAREoct, which functions in EC cells as a binding site for positive regulators of transcription and in RA-differentiated EC cells as a binding site for positive regulators of transcription and in RA- differentiated EC cells as a binding site for negative regulators. Our present results demonstrate that in P19 and RA-treated P19 cells, the orphan receptors ARP-1/COUP-TFII and EAR-3/COUP-TFI repress Oct-3/4 promoter activity through the RAREoct site in a dose-dependent manner. While the N-terminal region of the ARP-1/COUP-TFII receptor is dispensable for this repression, the C-terminal domain harbors the silencing region. Interestingly, three different RA receptor:retinoid X receptor (RAR:RXR) heterodimers, RAR alpha:RXR alpha, RAR beta:RXR alpha, and RAR beta:RXR beta, specifically bind and activate Oct-3/4 promoter through the RAREoct site in a ligand-dependent manner. We have shown that antagonism between ARP-1/COUP-TFII or EAR-3/COUP-TFI and the RAR:RXR heterodimers and their intracellular balance modulate Oct-3/4 expression. Oct-3/4 transcriptional repression by the orphan receptors can be overcome by increasing amounts of RAR:RXR heterodimers. Conversely, activation of Oct-3/4 promoter by RAR:RXR heterodimers was completely abolished by EAR-3/COUP-TFI and by ARP-1/COUP-TFII. The orphan receptors bind the RAREoct site with a much higher affinity than the RAR:RXR heterodimers. This high binding affinity provides ARP- 1/COUP-TFII and EAR-3/COUP-TFI with the ability to compete with and even displace RAR:RXR from the RAREoct site and subsequently to actively silence the Oct-3/4 promoter. We have shown that RA treatment of EC cells results in up-regulation of ARP-1/COUP-TFII and EAR-3/COUP- TFI expression. Most interestingly, in RA-treated EC cells, the kinetics of Oct-3/4 repression inversely correlates with the kinetics of ARP-1/COUP-TFII and EAR-3/COUP-TFI activation. These findings are in accordance with the suggestion that these orphan receptors participate in controlling a network of transcription factors, among which Oct-3/4 is included, which may establish the pattern of normal gene expression during development.


This article has been cited by other articles:

  • Stefanovic, S., Abboud, N., Desilets, S., Nury, D., Cowan, C., Puceat, M. (2009). Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. JCB 186: 665-673 [Abstract] [Full Text]  
  • Shyr, C.-R., Kang, H.-Y., Tsai, M.-Y., Liu, N.-C., Ku, P.-Y., Huang, K.-E., Chang, C. (2009). Roles of Testicular Orphan Nuclear Receptors 2 and 4 in Early Embryonic Development and Embryonic Stem Cells. Endocrinology 150: 2454-2462 [Abstract] [Full Text]  
  • Hochedlinger, K., Plath, K. (2009). Epigenetic reprogramming and induced pluripotency. Development 136: 509-523 [Abstract] [Full Text]  
  • Ura, H., Usuda, M., Kinoshita, K., Sun, C., Mori, K., Akagi, T., Matsuda, T., Koide, H., Yokota, T. (2008). STAT3 and Oct-3/4 Control Histone Modification through Induction of Eed in Embryonic Stem Cells. J. Biol. Chem. 283: 9713-9723 [Abstract] [Full Text]  
  • Lavial, F., Acloque, H., Bertocchini, F., MacLeod, D. J., Boast, S., Bachelard, E., Montillet, G., Thenot, S., Sang, H. M., Stern, C. D., Samarut, J., Pain, B. (2007). The Oct4 homologue PouV and Nanog regulate pluripotency in chicken embryonic stem cells. Development 134: 3549-3563 [Abstract] [Full Text]  
  • Niwa, H. (2007). How is pluripotency determined and maintained?. Development 134: 635-646 [Abstract] [Full Text]  
  • Urano, Y., Iiduka, M., Sugiyama, A., Akiyama, H., Uzawa, K., Matsumoto, G., Kawasaki, Y., Tashiro, F. (2006). Involvement of the Mouse Prp19 Gene in Neuronal/Astroglial Cell Fate Decisions. J. Biol. Chem. 281: 7498-7514 [Abstract] [Full Text]  
  • Chew, J.-L., Loh, Y.-H., Zhang, W., Chen, X., Tam, W.-L., Yeap, L.-S., Li, P., Ang, Y.-S., Lim, B., Robson, P., Ng, H.-H. (2005). Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells. Mol. Cell. Biol. 25: 6031-6046 [Abstract] [Full Text]  
  • Gu, P., Goodwin, B., Chung, A. C.-K., Xu, X., Wheeler, D. A., Price, R. R., Galardi, C., Peng, L., Latour, A. M., Koller, B. H., Gossen, J., Kliewer, S. A., Cooney, A. J. (2005). Orphan Nuclear Receptor LRH-1 Is Required To Maintain Oct4 Expression at the Epiblast Stage of Embryonic Development. Mol. Cell. Biol. 25: 3492-3505 [Abstract] [Full Text]  
  • Sheena, V., Hertz, R., Nousbeck, J., Berman, I., Magenheim, J., Bar-Tana, J. (2005). Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4{alpha}. J. Lipid Res. 46: 328-341 [Abstract] [Full Text]  
  • Hattori, N., Nishino, K., Ko, Y.-g., Hattori, N., Ohgane, J., Tanaka, S., Shiota, K. (2004). Epigenetic Control of Mouse Oct-4 Gene Expression in Embryonic Stem Cells and Trophoblast Stem Cells. J. Biol. Chem. 279: 17063-17069 [Abstract] [Full Text]  
  • Gidekel, S., Bergman, Y. (2002). A Unique Developmental Pattern of Oct-3/4 DNA Methylation Is Controlled by a cis-demodification Element. J. Biol. Chem. 277: 34521-34530 [Abstract] [Full Text]  
  • Fujikura, J., Yamato, E., Yonemura, S., Hosoda, K., Masui, S., Nakao, K., Miyazaki, J.-i., Niwa, H. (2002). Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev. 16: 784-789 [Abstract] [Full Text]  
  • Barnea, E., Bergman, Y. (2000). Synergy of SF1 and RAR in Activation of Oct-3/4 Promoter. J. Biol. Chem. 275: 6608-6619 [Abstract] [Full Text]  
  • Zhang, Y., Dufau, M. L. (2000). Nuclear Orphan Receptors Regulate Transcription of the Gene for the Human Luteinizing Hormone Receptor. J. Biol. Chem. 275: 2763-2770 [Abstract] [Full Text]  
  • Giguère, V. (1999). Orphan Nuclear Receptors: From Gene to Function. Endocr. Rev. 20: 689-725 [Abstract] [Full Text]  
  • Karperien, M., Farih-Sips, H., Hendriks, J. A.A., Lanske, B., Papapoulos, S. E., Abou-Samra, A.-B., Löwik, C. W.G.M., Defize, L. H.K. (1999). Identification of a Retinoic Acid-Inducible Element in the Murine PTH/PTHrP (Parathyroid Hormone/Parathyroid Hormone-Related Peptide) Receptor Gene. Mol. Endocrinol. 13: 1183-1196 [Abstract] [Full Text]  
  • Folkers, G. E., van der Burg, B., van der Saag, P. T. (1998). Promoter Architecture, Cofactors, and Orphan Receptors Contribute to Cell-specific Activation of the Retinoic Acid Receptor beta 2 Promoter. J. Biol. Chem. 273: 32200-32212 [Abstract] [Full Text]  
  • Lee, Y.-F., Young, W.-J., Burbach, J. P. H., Chang, C. (1998). Negative Feedback Control of the Retinoid-Retinoic Acid/Retinoid X Receptor Pathway by the Human TR4 Orphan Receptor, a Member of the Steroid Receptor Superfamily. J. Biol. Chem. 273: 13437-13443 [Abstract] [Full Text]  
  • Ben-Shushan, E., Thompson, J. R., Gudas, L. J., Bergman, Y. (1998). Rex-1, a Gene Encoding a Transcription Factor Expressed in the Early Embryo, Is Regulated via Oct-3/4 and Oct-6 Binding to an Octamer Site and a Novel Protein, Rox-1, Binding to an Adjacent Site. Mol. Cell. Biol. 18: 1866-1878 [Abstract] [Full Text]  
  • Tsai, S. Y., Tsai, M.-J. (1997). Chick Ovalbumin Upstream Promoter-Transcription Factors (COUP-TFs): Coming of Age. Endocr. Rev. 18: 229-240 [Abstract] [Full Text]  
  • Panariello, L., Quadro, L., Trematerra, S., Colantuoni, V. (1996). Identification of a Novel Retinoic Acid Response Element in the Promoter Region of the Retinol-binding Protein Gene. J. Biol. Chem. 271: 25524-25532 [Abstract] [Full Text]  
  • Yeom, Y., Fuhrmann, G, Ovitt, C., Brehm, A, Ohbo, K, Gross, M, Hubner, K, Scholer, H. (1996). Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122: 881-894 [Abstract]  
  • Tini, M., Fraser, R. A., Gigučre, V. (1995). Functional Interactions between Retinoic Acid Receptor-related Orphan Nuclear Receptor (RORalpha) and the Retinoic Acid Receptors in the Regulation of the [IMAGE]F-Crystallin Promoter. J. Biol. Chem. 270: 20156-20161 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»